Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior antiecolony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study Meeting Abstract
| Authors: | Serrano, C.; Blay, J. Y.; Rutkowski, P.; Gelderblom, H.; Stacchiotti, S.; Falcon Gonzalez, A.; Desai, J.; Le Cesne, A.; Ferraresi, V.; Palmerini, E.; Wilky, B. A.; Wagner, A. J.; Bernthal, N. M.; van de Sande, M.; Narasimhan, S.; Harrow, B.; Sharma, M. G.; Ruiz-Soto, R.; Sherman, M. L.; Tap, W. D. |
| Abstract Title: | Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior antiecolony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-11-01 |
| Start Page: | S1053 |
| Language: | English |
| ACCESSION: | WOS:001326612902389 |
| DOI: | 10.1016/j.annonc.2024.08.1860 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1769P -- Source: Wos |
